Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "zinc finger protein 106 homolog pseudogene" is a processed pseudogene in the human genome related to the functional gene ZNF106 (zinc finger protein 106). Pseudogenes are DNA sequences that resemble functional genes but have lost their protein-coding ability due to mutations or truncations in their sequence. This means they do not produce a functional protein product, and therefore are generally not considered meaningful therapeutic targets. Some pseudogenes may be transcribed into RNA and can, in rare cases, regulate their functional gene counterparts, but the zinc finger protein 106 homolog pseudogene has no established molecular function, disease association, or known role in human biology relevant to drug targeting. This molecule is not a receptor, enzyme, transporter, transcription factor, or other druggable target class. It provides no therapeutic relevance or known molecular function and is likely included in databases only for completeness in genome annotation.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 106 homolog pseudogene.